Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2008-5-29
pubmed:abstractText
Two single-nucleotide polymorphisms in the type 2 ryanodine receptor (RyR2) leading to the nonsynonymous amino acid replacements G1885E and G1886S are associated with arrhythmogenic right ventricular cardiomyopathy in patients who are carrying both of the corresponding RyR2 alleles. The functional properties of HEK293 cell lines isogenically expressing RyR2 mutants associated with arrhythmogenic right ventricular cardiomyopathy, RyR2-G1885E, RyR2-G1886S, RyR2-G1886D (mimicking a constitutively phosphorylated Ser(1886)), and the double mutant RyR2-G1885E/G1886S were investigated by analyzing the intracellular Ca(2+) release activity resulting from store-overload-induced calcium release. The substitution of serine for Gly(1886) caused a significant increase in the cellular Ca(2+) oscillation activity compared with RyR2 wild-type-expressing HEK293 cells. It was even more pronounced if glycine 1885 or 1886 was replaced by the acidic amino acids glutamate (G1885E) or aspartate (G1886D). Surprisingly, when both substitutions were introduced in the same RyR2 subunit (RyR2-G1885E/G1886S), the store-overload-induced calcium release activity was nearly completely abolished, although the Ca(2+) loading of the intracellular stores was markedly enhanced, and the channel still displayed substantial Ca(2+) release on stimulation by 5 mM caffeine. These results suggest that the adjacent glycines 1885 and 1886, located in the divergent region 3, are critical for the function and regulation of RyR2.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18326664-10512814, http://linkedlifedata.com/resource/pubmed/commentcorrection/18326664-11353864, http://linkedlifedata.com/resource/pubmed/commentcorrection/18326664-11429443, http://linkedlifedata.com/resource/pubmed/commentcorrection/18326664-12270947, http://linkedlifedata.com/resource/pubmed/commentcorrection/18326664-12446682, http://linkedlifedata.com/resource/pubmed/commentcorrection/18326664-12576471, http://linkedlifedata.com/resource/pubmed/commentcorrection/18326664-15081811, http://linkedlifedata.com/resource/pubmed/commentcorrection/18326664-15110152, http://linkedlifedata.com/resource/pubmed/commentcorrection/18326664-15276012, http://linkedlifedata.com/resource/pubmed/commentcorrection/18326664-15322274, http://linkedlifedata.com/resource/pubmed/commentcorrection/18326664-15967847, http://linkedlifedata.com/resource/pubmed/commentcorrection/18326664-16157601, http://linkedlifedata.com/resource/pubmed/commentcorrection/18326664-16214874, http://linkedlifedata.com/resource/pubmed/commentcorrection/18326664-16239587, http://linkedlifedata.com/resource/pubmed/commentcorrection/18326664-16391617, http://linkedlifedata.com/resource/pubmed/commentcorrection/18326664-16483256, http://linkedlifedata.com/resource/pubmed/commentcorrection/18326664-16769042, http://linkedlifedata.com/resource/pubmed/commentcorrection/18326664-17052226, http://linkedlifedata.com/resource/pubmed/commentcorrection/18326664-17259277, http://linkedlifedata.com/resource/pubmed/commentcorrection/18326664-17347175, http://linkedlifedata.com/resource/pubmed/commentcorrection/18326664-2744487, http://linkedlifedata.com/resource/pubmed/commentcorrection/18326664-8646541
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1542-0086
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
94
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4668-77
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
ARVC-related mutations in divergent region 3 alter functional properties of the cardiac ryanodine receptor.
pubmed:affiliation
Institut für Physiologische Chemie, Abteilung Biochemie Supramolekularer Systeme, Ruhr-Universität Bochum, 44780 Bochum, Germany.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't